Abstract
New insights into low high-density lipoprotein cholesterol identify promising new directions for coronary heart disease prevention. The ATP-binding-cassette A1 gene has been identified as an important defect in genetic disorders of this lipid fraction. Recent studies indicate a benefit in treating patients with low levels of high-density lipoprotein cholesterol and suggest new clinical recommendations.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 109-112 |
| Number of pages | 4 |
| Journal | Current Opinion in Pharmacology |
| Volume | 1 |
| Issue number | 2 |
| DOIs | |
| State | Published - Apr 1 2001 |
Keywords
- Apolipoprotein Al, ABC-A1
- Artherogenesis
- Atherosclerosis
- Coronary heart disease
- HDL cholesterol
- LDL cholesterol
- Molecular Medicine
- Pharmacology
- Physiology
- Triglycerides
ASJC Scopus subject areas
- Cellular and Molecular Neuroscience
- Pharmacology
Fingerprint
Dive into the research topics of 'High-density lipoprotein cholesterol: An updated view'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS